Home · Peptides · Tesofensine
THE PEPTIDE APP FIELD GUIDE · Metabolic SERIES FIELD SPECIMEN
Metabolic CATEGORY

Tesofensine

THE APPETITE CRUSHER

TE-1; NS2330

Tesofensine is a triple monoamine reuptake inhibitor that was originally developed for Parkinson's and Alzheimer's. It blocks reuptake of dopamine, norepinephrine, and serotonin, powerfully reducing appetite and increasing energy expenditure. In trials it produced greater weight loss than any other single agent, making it one of the most effective compounds for obesity.

Tesofensine
Tesofensine
Tesofensine

Tesofensine Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

Sep 1, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Tesofensine

◆

Is Tesofensine FDA approved?

No. This profile records Tesofensine as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Tesofensine?

Dose: 0.25-0.5 mg orally once daily.

MORE CONTEXT ›

Schedule: daily. Cycle: Ongoing with medical supervision. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Tesofensine guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Triple Reuptake Inhibition

Blocks DAT, NET, and SERT transporters

Appetite Suppression

Increases monoamines in hypothalamic feeding centers

Thermogenesis

Enhances sympathetic activity and energy expenditure

Cognitive Enhancement

Improves dopamine-mediated focus and motivation

Those with significant weight to lose
People who struggle with appetite control
hose who haven't responded to other weight loss drugs
Anyone wanting cognitive boost alongside weight loss

Tesofensine Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.